Ethoheptazine

Ethoheptazine

Ethoheptazine is a synthetic opioid analgesic drug that belongs to the class of phenazocine derivatives. It was first synthesized in the 1960s and was primarily used as a pain reliever. Ethoheptazine is known for its potent analgesic properties and has been used in various medical settings.

History

Ethoheptazine was developed by pharmaceutical company Merck in the 1960s. It was initially introduced as a safer alternative to other opioid analgesics available at the time. The drug gained popularity due to its effectiveness in managing moderate to severe pain.

Pharmacology

Ethoheptazine acts as a selective agonist of the μ-opioid receptor, which is responsible for mediating the analgesic effects of opioids. It also exhibits some affinity for the κ-opioid receptor. By binding to these receptors, ethoheptazine inhibits the transmission of pain signals in the central nervous system, resulting in pain relief.

Medical Uses

Ethoheptazine was primarily used for the management of moderate to severe pain. It was commonly prescribed for postoperative pain, cancer-related pain, and other chronic pain conditions. However, due to the potential for abuse and addiction, its use has been limited in recent years.

Side Effects

Like other opioids, ethoheptazine can cause various side effects. Common side effects include drowsiness, dizziness, constipation, nausea, and respiratory depression. Long-term use of ethoheptazine can lead to tolerance, dependence, and addiction.

Legal Status

The legal status of ethoheptazine varies from country to country. In some countries, it is classified as a controlled substance due to its potential for abuse and addiction. In other countries, it may be available only by prescription or completely banned.

References

<references />

See Also

• Opioid analgesics
• Phenazocine derivatives
• Pain management

Ethoheptazine

• 
  Ethoheptazine 2D Structure
• 
  Ethoheptazine 3D Model